|
A549
|
IC50 |
|
Antitumour activity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human A549 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
|
B16
|
IC50 |
|
Antitumour activity against mouse B16 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against mouse B16 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines breast MDA-MB-435
Cytotoxicity against the cancer cell lines breast MDA-MB-435
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines ovarian OVCAR-3
Cytotoxicity against the cancer cell lines ovarian OVCAR-3
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines CNS SF-539
Cytotoxicity against the cancer cell lines CNS SF-539
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines melanoma UACC-62
Cytotoxicity against the cancer cell lines melanoma UACC-62
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines colon HCT116
Cytotoxicity against the cancer cell lines colon HCT116
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines lung HOP-62
Cytotoxicity against the cancer cell lines lung HOP-62
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Concentration required to inhibit the growth of HOP-6 human lung cancer cells by 50%
Concentration required to inhibit the growth of HOP-6 human lung cancer cells by 50%
|
[PMID: 16078843]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines renal SN12C
Cytotoxicity against the cancer cell lines renal SN12C
|
[PMID: 12361402]
|
|
Cancer cell lines
|
GI50 |
|
Growth inhibitory concentration against human cancer cell line
Growth inhibitory concentration against human cancer cell line
|
[PMID: 15456256]
|
|
Cancer cell lines
|
GI50 |
|
Cytotoxicity against the cancer cell lines prostate DU-145
Cytotoxicity against the cancer cell lines prostate DU-145
|
[PMID: 12361402]
|
|
DU-145
|
GI50 |
1.2 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human DU145 cells at 96 hrs by WST1 assay
Antiproliferative activity against human DU145 cells at 96 hrs by WST1 assay
|
[PMID: 22247790]
|
|
DU-145
|
GI50 |
|
Antiproliferative activity against human DU145 cells after 96 hrs by WST1 assay
Antiproliferative activity against human DU145 cells after 96 hrs by WST1 assay
|
[PMID: 17696419]
|
|
DU-145
|
GI50 |
|
Antiproliferative activity against human DU145 cells
Antiproliferative activity against human DU145 cells
|
[PMID: 18260615]
|
|
DU-145
|
GI50 |
|
Antiproliferative activity against human DU145 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human DU145 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
DU-145
|
GI50 |
|
Growth inhibitory concentration against human prostate DU-145 cancer cell line
Growth inhibitory concentration against human prostate DU-145 cancer cell line
|
[PMID: 15456256]
|
|
DU-145
|
GI50 |
|
Cytotoxicity against human DU145 cells
Cytotoxicity against human DU145 cells
|
[PMID: 18052315]
|
|
DU-145
|
GI50 |
|
Cytotoxicity against prostate DU-145 cancer cell lines.
Cytotoxicity against prostate DU-145 cancer cell lines.
|
[PMID: 7783135]
|
|
DU-145
|
GI50 |
|
The In vitro cytotoxicity value corresponding to 50% growth inhibition against DU-145 (prostate) cell line.
The In vitro cytotoxicity value corresponding to 50% growth inhibition against DU-145 (prostate) cell line.
|
[PMID: 9240348]
|
|
DU-145
|
GI50 |
|
Concentration required to inhibit the growth of DU-145 human prostate cancer cells by 50%
Concentration required to inhibit the growth of DU-145 human prostate cancer cells by 50%
|
[PMID: 16078843]
|
|
HCT-116
|
GI50 |
|
Growth inhibitory concentration against human colon cancer HCT116 cell line
Growth inhibitory concentration against human colon cancer HCT116 cell line
|
[PMID: 15456256]
|
|
HCT-116
|
GI50 |
|
Cytotoxicity against human HCT116 cells
Cytotoxicity against human HCT116 cells
|
[PMID: 18052315]
|
|
HCT-116
|
GI50 |
|
Antiproliferative activity against human HCT116 cells
Antiproliferative activity against human HCT116 cells
|
[PMID: 18260615]
|
|
HCT-116
|
GI50 |
|
Antiproliferative activity against human HCT116 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human HCT116 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
HCT-116
|
GI50 |
|
Cytotoxicity against colon HCT116 cancer cell lines.
Cytotoxicity against colon HCT116 cancer cell lines.
|
[PMID: 7783135]
|
|
HCT-116
|
GI50 |
|
The In vitro cytotoxicity value is the concentration of the compound corresponding to 50% growth inhibition againstHCT-116 (colon) cell line.
The In vitro cytotoxicity value is the concentration of the compound corresponding to 50% growth inhibition againstHCT-116 (colon) cell line.
|
[PMID: 9240348]
|
|
HCT-116
|
GI50 |
|
Concentration required to inhibit the growth of HCT116 human colon cancer cells by 50%
Concentration required to inhibit the growth of HCT116 human colon cancer cells by 50%
|
[PMID: 16078843]
|
|
HEK-293T
|
IC50 |
4.6 μM
Compound: 2-methoxyestradiol
|
Cytotoxicity against HEK293T cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against HEK293T cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
|
HL-60
|
IC50 |
0.9 μM
Compound: Table 3 R4C1
|
Cytotoxicity against vincristine-resistant human HL60 cells after 72 hrs MTS assay
Cytotoxicity against vincristine-resistant human HL60 cells after 72 hrs MTS assay
|
[PMID: 20411988]
|
|
HL-60
|
IC50 |
3.4 μM
Compound: Table 3 R4C1
|
Cytotoxicity against human HL60 cells after 72 hrs MTS assay
Cytotoxicity against human HL60 cells after 72 hrs MTS assay
|
[PMID: 20411988]
|
|
HOP-62
|
GI50 |
|
Growth inhibitory concentration against human lung cancer HOP-62 cell line
Growth inhibitory concentration against human lung cancer HOP-62 cell line
|
[PMID: 15456256]
|
|
HOP-62
|
GI50 |
|
Cytotoxicity against human HOP62 cells
Cytotoxicity against human HOP62 cells
|
[PMID: 18052315]
|
|
HOP-62
|
GI50 |
|
Antiproliferative activity against human HOP62 cells
Antiproliferative activity against human HOP62 cells
|
[PMID: 18260615]
|
|
HOP-62
|
GI50 |
|
Antiproliferative activity against human HOP62 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human HOP62 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
HOP-62
|
GI50 |
|
Cytotoxicity against lung HOP-62 cancer cell lines.
Cytotoxicity against lung HOP-62 cancer cell lines.
|
[PMID: 7783135]
|
|
HOP-62
|
GI50 |
|
The In vitro cytotoxicity value is the concentration corresponding to 50% growth inhibition against HOP-62 (non small cell lung) cell line.
The In vitro cytotoxicity value is the concentration corresponding to 50% growth inhibition against HOP-62 (non small cell lung) cell line.
|
[PMID: 9240348]
|
|
HUVEC
|
IC50 |
|
Antiangiogenic activity in HUVEC assessed as inhibition of cell proliferation
Antiangiogenic activity in HUVEC assessed as inhibition of cell proliferation
|
[PMID: 19782568]
|
|
HUVEC
|
IC50 |
0.68 μM
Compound: 2ME2, Panzem
|
Antiangiogenic activity against HUVEC assessed as growth inhibition after 48 hrs by WST1 assay
Antiangiogenic activity against HUVEC assessed as growth inhibition after 48 hrs by WST1 assay
|
[PMID: 19782564]
|
|
HUVEC
|
IC50 |
|
Growth inhibitory concentration against MDA-MB-231 cancer cell line
Growth inhibitory concentration against MDA-MB-231 cancer cell line
|
[PMID: 15456256]
|
|
HUVEC
|
IC50 |
0.84 μM
Compound: 1, 2ME2
|
Antiproliferative activity against human HUVECs after 48 hrs
Antiproliferative activity against human HUVECs after 48 hrs
|
[PMID: 17910916]
|
|
HUVEC
|
IC50 |
|
Antiangiogenic activity against HUVECs by Brdu incorporation assay
Antiangiogenic activity against HUVECs by Brdu incorporation assay
|
[PMID: 19762246]
|
|
HUVEC
|
IC50 |
14.17 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against HUVEC after 48 hrs by MTT assay
Antiproliferative activity against HUVEC after 48 hrs by MTT assay
|
[PMID: 28810190]
|
|
HUVEC
|
IC50 |
|
Antiangiogenic activity against HUVEC cells assessed as inhibition of proliferation
Antiangiogenic activity against HUVEC cells assessed as inhibition of proliferation
|
[PMID: 18260615]
|
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells expressing tubulin 3beta by sulforhodamine B assay
Antiproliferative activity against human HeLa cells expressing tubulin 3beta by sulforhodamine B assay
|
[PMID: 20973488]
|
|
HeLa
|
IC50 |
|
Antiproliferative activity against human HeLa cells by sulforhodamine B assay
Antiproliferative activity against human HeLa cells by sulforhodamine B assay
|
[PMID: 20973488]
|
|
HeLa
|
IC50 |
8.6 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
|
HepG2
|
IC50 |
11.03 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
|
HepG2
|
IC50 |
2.3 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
|
Ishikawa
|
IC50 |
8.96 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human Ishikawa cells after 48 hrs by MTT assay
Antiproliferative activity against human Ishikawa cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
|
K562
|
IC50 |
|
Anticancer activity against human K562 cells assessed as cell growth inhibition after 5 days by MTT assay
Anticancer activity against human K562 cells assessed as cell growth inhibition after 5 days by MTT assay
|
[PMID: 25108078]
|
|
LNCaP
|
IC50 |
|
Antiproliferative activity against human LNCaP cell line
Antiproliferative activity against human LNCaP cell line
|
[PMID: 16650989]
|
|
MCF7
|
GI50 |
|
Antiproliferative activity against estrogen receptor positive human MCF7 cells
Antiproliferative activity against estrogen receptor positive human MCF7 cells
|
[PMID: 18260615]
|
|
MCF7
|
GI50 |
|
Inhibition of the growth of human breast cancer MCF-7 cells done for 2 hr at 37 degree C with compound
Inhibition of the growth of human breast cancer MCF-7 cells done for 2 hr at 37 degree C with compound
|
[PMID: 16078843]
|
|
MCF7
|
GI50 |
|
Growth inhibition of human MCF7 cells
Growth inhibition of human MCF7 cells
|
[PMID: 25992880]
|
|
MCF7
|
IC50 |
0.842 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human MCF7 cells after 72 hrs by crystal violet biomass reduction assay
Antiproliferative activity against human MCF7 cells after 72 hrs by crystal violet biomass reduction assay
|
[PMID: 20334421]
|
|
MCF7
|
IC50 |
2.39 μM
Compound: 1 (2-MeOE2)
|
Anti-proliferative activity against MCF-7 human breast cancer cells was determined by using MCF-7 plate assay
Anti-proliferative activity against MCF-7 human breast cancer cells was determined by using MCF-7 plate assay
|
[PMID: 15149660]
|
|
MCF7
|
IC50 |
6.01 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
|
MCF7
|
IC50 |
> 70 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
|
MDA-MB-231
|
GI50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST1 assay
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST1 assay
|
[PMID: 17696419]
|
|
MDA-MB-231
|
GI50 |
|
Antiproliferative activity against estrogen receptor negative human MDA-MB-231 cells
Antiproliferative activity against estrogen receptor negative human MDA-MB-231 cells
|
[PMID: 18260615]
|
|
MDA-MB-231
|
GI50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
MDA-MB-231
|
IC50 |
0.25 μM
Compound: 2-methoxyestradiol
|
Inhibition of estrogen receptor negative MDA-MB 231 breast cancer cell proliferation at 1 uM
Inhibition of estrogen receptor negative MDA-MB 231 breast cancer cell proliferation at 1 uM
|
[PMID: 9357519]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells
Antiproliferative activity against human MDA-MB-231 cells
|
[PMID: 19782568]
|
|
MDA-MB-231
|
IC50 |
0.79 μM
Compound: 2ME2, Panzem
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by WST1 assay
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by WST1 assay
|
[PMID: 19782564]
|
|
MDA-MB-231
|
IC50 |
|
Growth inhibitory concentration against HUVEC cancer cell line
Growth inhibitory concentration against HUVEC cancer cell line
|
[PMID: 15456256]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs
Antiproliferative activity against human MDA-MB-231 cells after 48 hrs
|
[PMID: 17910916]
|
|
MDA-MB-231
|
IC50 |
5 μM
Compound: 2-methoxyestradiol
|
Inhibition of estrogen receptor negative MDA-MB 231 breast cancer cell proliferation at 10 uM
Inhibition of estrogen receptor negative MDA-MB 231 breast cancer cell proliferation at 10 uM
|
[PMID: 9357519]
|
|
MDA-MB-435
|
GI50 |
|
Growth inhibitory concentration against human breast MDA-MB-435 cancer cell line
Growth inhibitory concentration against human breast MDA-MB-435 cancer cell line
|
[PMID: 15456256]
|
|
MDA-MB-435
|
GI50 |
|
Cytotoxicity against human MDA-MB-435 cells
Cytotoxicity against human MDA-MB-435 cells
|
[PMID: 18052315]
|
|
MDA-MB-435
|
GI50 |
|
Antiproliferative activity against human MDA-MB-435 cells
Antiproliferative activity against human MDA-MB-435 cells
|
[PMID: 18260615]
|
|
MDA-MB-435
|
GI50 |
|
Cytotoxicity against breast MDA-MB-435 cancer cell lines.
Cytotoxicity against breast MDA-MB-435 cancer cell lines.
|
[PMID: 7783135]
|
|
MDA-MB-435
|
GI50 |
|
In vitro cytotoxicity value corresponding to 50% growth inhibition against MDA-MB-435 (breast) cell line.
In vitro cytotoxicity value corresponding to 50% growth inhibition against MDA-MB-435 (breast) cell line.
|
[PMID: 9240348]
|
|
MDA-MB-435
|
GI50 |
|
Concentration required to inhibit the growth of MDA-MB-435 human breast cancer cells by 50%
Concentration required to inhibit the growth of MDA-MB-435 human breast cancer cells by 50%
|
[PMID: 16078843]
|
|
MDA-MB-435
|
IC50 |
|
Antiproliferative activity against human MDA-MB-435 cells by Brdu incorporation assay
Antiproliferative activity against human MDA-MB-435 cells by Brdu incorporation assay
|
[PMID: 19762246]
|
|
MGC-803
|
IC50 |
|
Antitumour activity against human MGC803 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human MGC803 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
|
OVCAR-3
|
GI50 |
|
Growth inhibitory concentration against human ovarian OVCAR-3 cancer cell line
Growth inhibitory concentration against human ovarian OVCAR-3 cancer cell line
|
[PMID: 15456256]
|
|
OVCAR-3
|
GI50 |
|
Cytotoxicity against human OVCAR-3 cells
Cytotoxicity against human OVCAR-3 cells
|
[PMID: 18052315]
|
|
OVCAR-3
|
GI50 |
|
Antiproliferative activity against human OVCAR-3 cells
Antiproliferative activity against human OVCAR-3 cells
|
[PMID: 18260615]
|
|
OVCAR-3
|
GI50 |
|
Antiproliferative activity against human OVCAR-3 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human OVCAR-3 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
OVCAR-3
|
GI50 |
|
Cytotoxicity against ovarian OVCAR-3 cancer cell lines.
Cytotoxicity against ovarian OVCAR-3 cancer cell lines.
|
[PMID: 7783135]
|
|
OVCAR-3
|
GI50 |
|
In vitro cytotoxicity value corresponding to 50% growth inhibition against OVCAR-3 (ovarian) cell line.
In vitro cytotoxicity value corresponding to 50% growth inhibition against OVCAR-3 (ovarian) cell line.
|
[PMID: 9240348]
|
|
OVCAR-3
|
GI50 |
|
Concentration required to inhibit the growth of OVCAR-3 human ovarian cancer cells by 50%
Concentration required to inhibit the growth of OVCAR-3 human ovarian cancer cells by 50%
|
[PMID: 16078843]
|
|
OVCAR-3
|
IC50 |
|
Anticancer activity against human OVCAR3 cells assessed as cell growth inhibition after 5 days by MTT assay
Anticancer activity against human OVCAR3 cells assessed as cell growth inhibition after 5 days by MTT assay
|
[PMID: 25108078]
|
|
PC-3
|
IC50 |
12.31 μM
Compound: 2; 2-ME2
|
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 48 hrs by MTT assay
|
[PMID: 28810190]
|
|
PC-3
|
IC50 |
|
Antiproliferative activity against human PC3 cells by Brdu incorporation assay
Antiproliferative activity against human PC3 cells by Brdu incorporation assay
|
[PMID: 19762246]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against human PC3 cells after 72 hrs by CellTiter one aqueous solution assay
Cytotoxicity against human PC3 cells after 72 hrs by CellTiter one aqueous solution assay
|
[PMID: 31195168]
|
|
Panel (Carcinoma cell lines)
|
GI50 |
|
Mean graph midpoint for all human cancer cell line cytotoxicity.
Mean graph midpoint for all human cancer cell line cytotoxicity.
|
[PMID: 7783135]
|
|
Panel (Carcinoma cell lines)
|
GI50 |
|
Mean graph midpoint for growth inhibition of all human cancer cell lines
Mean graph midpoint for growth inhibition of all human cancer cell lines
|
[PMID: 9240348]
|
|
SF-539
|
GI50 |
|
Growth inhibitory concentration against human CNS SF-539 cancer cell line
Growth inhibitory concentration against human CNS SF-539 cancer cell line
|
[PMID: 15456256]
|
|
SF-539
|
GI50 |
|
Cytotoxicity against human SF539 cells
Cytotoxicity against human SF539 cells
|
[PMID: 18052315]
|
|
SF-539
|
GI50 |
|
Antiproliferative activity against human SF539 cells at
Antiproliferative activity against human SF539 cells at
|
[PMID: 18260615]
|
|
SF-539
|
GI50 |
|
Antiproliferative activity against human SF539 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human SF539 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
SF-539
|
GI50 |
|
Cytotoxicity against CNS SF-539 cancer cell lines.
Cytotoxicity against CNS SF-539 cancer cell lines.
|
[PMID: 7783135]
|
|
SF-539
|
GI50 |
|
The In vitro cytotoxicity corresponding to 50% growth inhibition against SF-59 (central nervous system) cell line.
The In vitro cytotoxicity corresponding to 50% growth inhibition against SF-59 (central nervous system) cell line.
|
[PMID: 9240348]
|
|
SF-539
|
GI50 |
|
Concentration required to inhibit the growth of SF-539 human CNS cancer cells by 50%
Concentration required to inhibit the growth of SF-539 human CNS cancer cells by 50%
|
[PMID: 16078843]
|
|
SK-N-SH
|
IC50 |
|
Antitumour activity against human SK-N-SH cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human SK-N-SH cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
|
SK-OV-3
|
IC50 |
16.5 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
|
SK-OV-3
|
IC50 |
|
Antiproliferative activity against human SKOV3 cells expressing MDR1-6/6 by sulforhodamine B assay
Antiproliferative activity against human SKOV3 cells expressing MDR1-6/6 by sulforhodamine B assay
|
[PMID: 20973488]
|
|
SK-OV-3
|
IC50 |
|
Antiproliferative activity against human SKOV3 cells by sulforhodamine B assay
Antiproliferative activity against human SKOV3 cells by sulforhodamine B assay
|
[PMID: 20973488]
|
|
SMMC-7721
|
IC50 |
|
Antitumour activity against human SMMC7721 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
Antitumour activity against human SMMC7721 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay
|
[PMID: 31102934]
|
|
SN12C
|
GI50 |
|
Growth inhibitory concentration against human renal SN12C cancer cell line
Growth inhibitory concentration against human renal SN12C cancer cell line
|
[PMID: 15456256]
|
|
SN12C
|
GI50 |
|
Cytotoxicity against human SN12C cells
Cytotoxicity against human SN12C cells
|
[PMID: 18052315]
|
|
SN12C
|
GI50 |
|
Antiproliferative activity against human SN12-C cells
Antiproliferative activity against human SN12-C cells
|
[PMID: 18260615]
|
|
SN12C
|
GI50 |
|
Antiproliferative activity against human SN12C cells after 96 hrs by WST-1 assay
Antiproliferative activity against human SN12C cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
SN12C
|
GI50 |
|
Cytotoxicity against renal SN12C cancer cell lines.
Cytotoxicity against renal SN12C cancer cell lines.
|
[PMID: 7783135]
|
|
SN12C
|
GI50 |
|
In vitro cytotoxicity value corresponding to 50% growth inhibition against SN12C (renal) cell line.
In vitro cytotoxicity value corresponding to 50% growth inhibition against SN12C (renal) cell line.
|
[PMID: 9240348]
|
|
SN12C
|
GI50 |
|
Concentration required to inhibit the growth of SN12C human renal cancer cells by 50%
Concentration required to inhibit the growth of SN12C human renal cancer cells by 50%
|
[PMID: 16078843]
|
|
T47D
|
IC50 |
25.2 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human T47D cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human T47D cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36455509]
|
|
U-87MG ATCC
|
IC50 |
|
Antiproliferative activity against human U87MG cells by Brdu incorporation assay
Antiproliferative activity against human U87MG cells by Brdu incorporation assay
|
[PMID: 19762246]
|
|
U-937
|
IC50 |
2.91 μM
Compound: 2-methoxyestradiol
|
Antiproliferative activity against human U937 cells by sulforhodamine B assay
Antiproliferative activity against human U937 cells by sulforhodamine B assay
|
[PMID: 20334421]
|
|
UACC-62
|
GI50 |
|
Growth inhibitory concentration against human melanoma UACC-62 cancer cell line
Growth inhibitory concentration against human melanoma UACC-62 cancer cell line
|
[PMID: 15456256]
|
|
UACC-62
|
GI50 |
|
Cytotoxicity against human UACC62 cells
Cytotoxicity against human UACC62 cells
|
[PMID: 18052315]
|
|
UACC-62
|
GI50 |
|
Antiproliferative activity against human UACC62 cells
Antiproliferative activity against human UACC62 cells
|
[PMID: 18260615]
|
|
UACC-62
|
GI50 |
|
Antiproliferative activity against human UACC62 cells after 96 hrs by WST-1 assay
Antiproliferative activity against human UACC62 cells after 96 hrs by WST-1 assay
|
[PMID: 20225862]
|
|
UACC-62
|
GI50 |
|
Cytotoxicity against melanoma UACC-62 cancer cell lines.
Cytotoxicity against melanoma UACC-62 cancer cell lines.
|
[PMID: 7783135]
|
|
UACC-62
|
GI50 |
|
In vitro cytotoxicity value corresponding to 50% growth inhibition against UACC-62(melanoma) cell line.
In vitro cytotoxicity value corresponding to 50% growth inhibition against UACC-62(melanoma) cell line.
|
[PMID: 9240348]
|
|
UACC-62
|
GI50 |
|
Concentration required to inhibit the growth of UACC-62 human melanoma cells by 50%
Concentration required to inhibit the growth of UACC-62 human melanoma cells by 50%
|
[PMID: 16078843]
|